These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36633254)

  • 61. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.
    Zempel H; Thies E; Mandelkow E; Mandelkow EM
    J Neurosci; 2010 Sep; 30(36):11938-50. PubMed ID: 20826658
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
    He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
    Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules.
    Cho JH; Johnson GV
    J Neurochem; 2004 Jan; 88(2):349-58. PubMed ID: 14690523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs.
    Gustke N; Steiner B; Mandelkow EM; Biernat J; Meyer HE; Goedert M; Mandelkow E
    FEBS Lett; 1992 Jul; 307(2):199-205. PubMed ID: 1644173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease.
    Brion JP; Tremp G; Octave JN
    Am J Pathol; 1999 Jan; 154(1):255-70. PubMed ID: 9916940
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
    Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
    Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.
    Alonso AC; Grundke-Iqbal I; Iqbal K
    Nat Med; 1996 Jul; 2(7):783-7. PubMed ID: 8673924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
    Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
    Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization.
    Shirafuji N; Hamano T; Yen SH; Kanaan NM; Yoshida H; Hayashi K; Ikawa M; Yamamura O; Kuriyama M; Nakamoto Y
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562600
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tau phosphorylation affects its axonal transport and degradation.
    Rodríguez-Martín T; Cuchillo-Ibáñez I; Noble W; Nyenya F; Anderton BH; Hanger DP
    Neurobiol Aging; 2013 Sep; 34(9):2146-57. PubMed ID: 23601672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alzheimer disease hyperphosphorylated tau aggregates hydrophobically.
    Ruben GC; Ciardelli TL; Grundke-Iqbal I; Iqbal K
    Synapse; 1997 Nov; 27(3):208-29. PubMed ID: 9329157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer disease.
    Pradeepkiran JA; Munikumar M; Reddy AP; Reddy PH
    Hum Mol Genet; 2021 Dec; 31(2):244-261. PubMed ID: 34432046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.